Synapse Open Synapse
Biology

Roche affirms sales outlook amid doubts about its future

BioPharma Dive · · 2 min read

Lower-than-expected sales of Xolair stood out as the Swiss drugmaker readies for an onslaught of generic competition for top products.

Latest from BioPharma Dive